Navigation Links
CIOs of GlaxoSmithKline and British American Tobacco to Speak at Leading Enterprise Mobility Strategy Event
Date:4/30/2013

LONDON, April 30, 2013 /PRNewswire/ --

This year, 100 strategic decision-makers will meet at the Enterprise Mobility Exchange (21-23 May 2013, Rotterdam) to discuss the challenges presented in achieving best-in-breed operational efficiency, productivity and exceptional customer service through enterprise mobility.

We are pleased to confirm that Daniel Lebeau , Group CIO, GlaxoSmithKline, Phil Colman , CIO of British American Tobacco and J will be speaking and sharing their expertise at the Enterprise Mobility Exchange; widely acknowledged as the must-attend meeting for CIOs, VP's and Directors of Enterprise Mobility and IT.

The 2013 expert speaker panel also includes Jose Maria Boixeda de Miquel, CTO, gasNatural fenosa, Joe Norton , Deputy CIO of Philips IT and Cisco Sanchez, Managing Director, FedEx Express EMEA, along with strategic mobility leaders from National Grid and Shell.

The Enterprise Mobility Exchange is an invitation-only meeting for qualifying senior decision makers and a select group of innovative solution providers.

Further information about the industry leading speaker faculty and the latest agenda, along with details of how to request an invitation, can be found at http://www.enterprisemobilityexchange.com/EU/PR

About the Enterprise Mobility Exchange Network

The Enterprise Mobility Exchange Network host a series of invitation only forums designed to help senior strategy makers overcome their most pressing mobility challenges. Exchange only invites executives with the highest credentials, and solution providers with the most cutting edge capabilities, to deliver a unique business development opportunity and true peer-to-peer learning and networking forum.  http://www.enterprisemobilityexchange.com/PR  

About IQPC Exchange

IQPC Exchange provides business executives around the world with tailored practical conferences, large scale events, topical seminars and in-house training programs, keeping them up-to-date with industry trends, technological developments and the regulatory landscape

Media contact: Kira Stancliffe , +44(0)207-368-9796, kira.stancliffe@iqpcexchange.com or visit
http://www.enterprisemobilityexchange.com/EU/PR


'/>"/>
SOURCE IQPC Exchange
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. GlaxoSmithKline CFO Interviewed on Q1 2013 Financial Results
2. GlaxoSmithKline and A*STARs Institute of Chemical Engineering and Sciences to Develop new Medicines for Emerging Markets
3. GlaxoSmithKline and Liberty Property Trust/Synterra Partners Transform the Work Environment with the Opening of Five Crescent Drive Today
4. GlaxoSmithKline and Liberty Property Trust/Synterra Partners Transform the Work Environment with the Opening of Five Crescent Drive
5. Texas A&M System and GlaxoSmithKline receive U.S. Government approval to establish influenza vaccine facility in Texas
6. Isis Initates Phase 2/3 Study Of ISIS-TTR Rx And Earns $7.5 Million Milestone Payment From GlaxoSmithKline
7. GlaxoSmithKline advances multi-city discussion focused on improving the health of US communities
8. Fred Hutchinson Cancer Research Center Partners With GlaxoSmithKline to Develop Muscular Dystrophy Therapeutics
9. GlaxoSmithKline honors healthcare nonprofits with $40,000 IMPACT Award
10. GlaxoSmithKline Sales Down in Q3 against Good Underlying Momentum in the Business
11. Grant & Eisenhofer Represents Key Whistleblower in Justice Dept.s $1.04 Billion Civil Settlement with GlaxoSmithKline
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/13/2017)... June 13, 2017 Zimmer Biomet Holdings, Inc. (NYSE ... announced that the U.S. Food and Drug Administration (FDA) has ... 2015 relating to its Zhejiang, China ... "The successful clearance of the Warning Letter related ... facility is a measure of the progress we have made ...
(Date:6/11/2017)... and Company (NYSE: LLY ) announced today ... an investigational treatment for the prevention of episodic and ... endpoints for galcanezumab compared to placebo at both studied ... REGAIN) will be presented today at the American Headache ... . "The detailed Phase 3 ...
(Date:6/9/2017)... PALO ALTO, Calif. , June 9, 2017 /PRNewswire/ ... medical device company focused on the design, manufacture, sale ... updated the market on the progress of its commercial ... AeroForm is now available in more than one hundred ... country. AeroForm offers a needle-free alternative ...
Breaking Medicine Technology:
(Date:6/24/2017)... ... June 24, 2017 , ... ... at the Sheraton Erie Bayfront and Erie Convention Center on June 8-10. ... exhibits, a student quiz bowl, award and scholarship presentations, and professional networking. ...
(Date:6/23/2017)... ... 23, 2017 , ... The Rhode Island Quality Institute (RIQI) ... and Dashboards, an innovative new service enabling healthcare providers to proactively coordinate care ... and Dashboards provide near real-time data about patients admitted to and/or discharged from ...
(Date:6/23/2017)... (PRWEB) , ... June 24, 2017 , ... Studies show ... significantly reduce the risk of visual loss in these patients. , But how often ... diet, or smoking cessation to patients at risk of or with early symptoms of ...
(Date:6/23/2017)... ... ... Everybody has their own personal preference when it comes to pornography. Some ... don't like it at all. FindaTopDoc took a look at what makes people attracted ... readers a taste of their deepest, darkest fantasies and has the ability to help ...
(Date:6/23/2017)... , ... June 23, 2017 , ... ... Cancer Conference from Sept. 18 to 20. , The two-day conference is focused ... with the goal of improving patients’ lives and eliminating racial breast cancer-related disparities. ...
Breaking Medicine News(10 mins):